M&T Bank
PACB icon

M&T Bank’s Pacific Biosciences PACB Stock Holding History

M&T Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8K Buy
+26,688
New +$38.8K ﹤0.01% 1738
2014
Q4 		– Sell
-10,560
Closed -$52K – 2209
2014
Q3 		$52K Buy
+10,560
New +$55.2K ﹤0.01% 2082

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

M&T Bank's PACB Position: Q2 2026 in Review

M&T Bank opened a new position in Pacific Biosciences (PACB) in Q2 2026: 26,688 shares worth $44.8K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings. This is a return to the name: M&T Bank previously reported a position in PACB as recently as Q3 2014.

M&T Bank first reported a position in PACB in Q3 2014 and has held it in 2 quarters since. The position peaked at $52K in Q3 2014. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • M&T Bank held 26,688 shares of Pacific Biosciences worth $44.8K as of Q2 2026.
  • Pacific Biosciences was a new M&T Bank position in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1738 holding.
  • M&T Bank first reported a position in Pacific Biosciences in Q3 2014 and has held it in 2 quarters since.
  • M&T Bank's Pacific Biosciences position peaked at $52K in Q3 2014.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.